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Abstract Survival after in-hospital cardiac arrest (I-HCA)
remains\30 %. There is very limited literature exploring
the electrocardiogram changes prior to I-HCA. The purpose
of the study was to determine demographics and electro-
cardiographic predictors prior to I-HCA. A retrospective
study was conducted among 39 cardiovascular subjects who
had cardiopulmonary resuscitation from I-HCA with initial
rhythms of pulseless electrical activity (PEA) and asystole.
Demographics including medical history, ejection fraction,
laboratory values, and medications were examined. Elec-
trocardiogram (ECG) parameters from telemetry were
studied to identify changes in heart rate, QRS duration and
morphology, and time of occurrence and location of ST
segment changes prior to I-HCA. Increased age was signif-
icantly associated with failure to survive to discharge
(p\ 0.05). Significant change was observed in heart rate
including a downtrend of heart rate within 15 min prior to
I-HCA (p\ 0.05). Therewas a significant difference in heart
rate and QRS duration during the last hour prior to I-HCA
compared to the previous hours (p\ 0.05). Inferior ECG
leads showed the most significant changes in QRS mor-
phology and ST segments prior to I-HCA (p\ 0.05). Sub-
jects with an initial rhythm of asystole demonstrated
significantly greater ECG changes including QRS mor-
phology and ST segment changes compared to the subjects
with initial rhythms of PEA (p\ 0.05). Diagnostic ECG
trends can be identified prior to I-HCA due to PEA and
asystole and can be further utilized for training a predictive
machine learning model for I-HCA.
M. Attin (&)
School of Nursing, San Diego State University, 5500 Campanile
Drive, San Diego, CA 92182, USA
e-mail: mattin@mail.sdsu.edu
G. Feld
Department of Medicine, Cardiology Division,
Electrophysiology Section, University of California, San Diego,
San Diego, CA, USA
H. Lemus
School of Public Health, San Diego State University, San Diego,
CA, USA
K. Najarian
Department of Computational Medicine and Bioinformatics,
Michigan Center for Integrative Research in Critical Care,
University of Michigan, Ann Arbor, MI, USA
K. Najarian
Department of Emergency Medicine, Michigan Center for
Integrative Research in Critical Care, University of Michigan,
Ann Arbor, MI, USA
K. Najarian
Department of Computer Science and Engineering, Michigan
Center for Integrative Research in Critical Care, University of
Michigan, Ann Arbor, MI, USA
S. Shandilya
SciCore Technology, Richmond, VA, USA
L. Wang  P. Sabouriazad
Department of Bioengineering, College of Engineering, San
Diego State University, San Diego, CA, USA
C.-D. Lin
Department of Mathematics and Statistics, San Diego State
University, San Diego, CA, USA
123
J Clin Monit Comput (2015) 29:385–392
DOI 10.1007/s10877-014-9616-0
Keywords In-hospital cardiac arrest  Asystole 
Pulseless electrical activity  Electrocardiogram
1 Introduction
In-hospital cardiac arrest (I-HCA) accounts for approxi-
mately 200,000 cardiac arrests in the United States each
year [1] and survival to discharge after cardiopulmonary
resuscitation is less than 30 % [2]. Overall predictors of
poor survival among hospitalized subjects with I-HCA
include age, metastatic malignancy, impaired renal func-
tion and dependent functional status [3]. However it is not
clear whether I-HCA patients with known heart diseases
have similar survival predictors.
Approximately 70 % of initial rhythms in patients with
I-HCA are pulseless electrical activity (PEA) and asystole,
and these rhythms are associatedwith highermortality rates as
compared to initial rhythms of ventricular tachycardia and
fibrillation [4–6]. Telemetry use in-hospital is recognized as
an independent predictor of survival to discharge regardless of
rhythm prior to I-HCA [7]. Although electrocardiogram
(ECG) predictors of ventricular tachycardia and ventricular
fibrillation are well-studied, ECG predictors of PEA and
asystole are not. Identifying ECG changes prior to PEA and
asystole in patients with known heart diseases may provide
diagnostic clues that will lead to prevention or more timely
treatments of I-HCA in such cases. For example, the chance of
survival to hospital discharge is reportedly doubled among
patients who receive cardiopulmonary resuscitation (CPR)
within the first minute after cardiac arrest in comparison with
those who received CPR after more than aminute had elapsed
[8]. Thus, our study was designed to determine whether ECG
indicator(s) may predict I-HCA due to PEA or asystole in
patients with cardiovascular diseases, which then might be
used to shorten response time and improve treatment to
increase the likelihood of successful resuscitation and dis-
charge from the hospital.
2 Methods
2.1 Study design and setting
A retrospective study was conducted among subjects who
experienced I-HCA with an initial rhythm of PEA or
asystole in the medical and surgical intensive care units
(ICU) and step-down units of three acute care hospitals.
All I-HCA subjects were on continuous ECG monitoring
(e.g., five lead ECG telemetry) prior to I-HCA, per
standard of care required by each hospital, for the entire
duration of stay of these patients in the ICU or step down
units.
2.2 Study population
Subjects who experienced I-HCA and underwent cardio-
pulmonary resuscitation (CPR) were screened from Febru-
ary 2010 to June 2012 for eligibility in the study. Subjects
were included if they were C21 years of age and had a his-
tory of structural heart diseases (see definitions below). If a
subject had more than one I-HCA, only the first episode of
I-HCA was included in the analysis. Subjects were excluded
from the study if resuscitation was initiated out-of-hospital,
in the emergency room, in a procedure or operating room, or
for trauma, drug overdose, hypothermia, drowning, or if they
had an active cancer (e.g., receiving chemo or radiation
therapy) or were comatose. Clinical characteristics of sub-
jects were obtained from themedical record. Laboratory data
including potassium, calcium, hemoglobin, blood urea
nitrogen and creatinine were obtained within 24–48 h of
I-HCA, and troponin and B-type natriuretic peptide (BNP)
levels were recorded if obtained during the same hospital-
ization in which I-HCA occurred. A list of cardiac medica-
tions, sedatives, and narcotics administrated within 72 h of
I-HCAwas obtained. Cardiac risk factors including a history
of diabetes, hypertension, and hyperlipidemia were noted.
The ejection fraction (EF) from any echocardiogram
obtained within 6 months prior to I-HCA was recorded. All
available 12-lead ECGs prior to I-HCA were examined for
evidence of bundle branch blocks.
2.3 ECG measurements
The full disclosure ECG prior to I-HCA from continuous
monitoring systems was obtained. The full disclosure ECG
was recorded at a paper speed of 25 mm/s, at 10 mm/mV
gain, and typically consisted of 7–8 ECG leads (i.e. I, II,
III, aVR, aVL, aVF, V1, V6). Since lead V6 was not rou-
tinely recorded in the majority of subjects, only seven leads
were used for analysis. Each full disclosure ECG was 10 s
long. Full disclosure ECGs were analyzed for 2 min at the
time of I-HCA and for any significant rhythm changes
within 1 h of documented I-HCA. Additionally, full dis-
closure ECG papers were analyzed for 2 min in each of the
8 h prior to I-HCA. All rhythms prior to I-HCA were
analyzed except for paced rhythms.
Heart rate was reported as the R–R interval. A decreased
heart ratewas defined as a decline in heart rateC15 beats/min
at any time within 15 min of cardiac arrest. QRS duration
was measured from the beginning of the Q wave (or R wave
in the absence of Q wave) to the end of the S wave in each
lead of the full disclosure ECG and the mean QRS duration
for each lead was calculated over three beats in each full
disclosure ECG paper. QRS prolongation was defined as an
increase in QRS duration C20 ms (ms) observed within 7 h
prior to I-HCA. QRS duration prior to I-HCA was noted in
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two ways: (1) a single longest QRS duration in any available
lead for each hour and (2) the longest mean QRS duration in
any available lead for each hour.
ST segment elevation or depression of C1 mm and QRS
morphology including notching, fractionated QRS (fQRS),
rSR0 and rSr0 in any availableECG leadwere identified visually
by experts including a physician (cardiac electrophysiologist)
and the primary author.We reportedonly those changes inQRS
morphology and ST segment elevation and depression that
werenot present initially at 8 hprior to arrest. The timebetween
I-HCAandchanges inQRSmorphology, ST segment elevation
and depression were obtained by recording the earliest change
that was present in any ECG lead. The ECG locations of the
earliest changes and subsequent changes were also recorded.
Subjects with left bundle branch block (LBBB) confirmed
through 12 lead ECG were not included in the sample set for
detecting ST segment changes.
Research assistants were trained to review and evaluate
ECG changes, and the correlation of measurements between
research assistants and primary investigators was[90 %. A
cardiac electrophysiologist was available as a consultant to
review the ECG data. Additionally, we digitized ECG paper
recordings for 39 subjects and performed automated mea-
surements including heart rate [9, 10]. The agreement
between manual and automated measurements was 93 %.
2.4 Definitions
For this study, cardiac arrest was defined as a sudden
cessation of cardiac function, precipitated by pulseless
electrical activity or asystole (ventricular tachycardia and
ventricular fibrillation were excluded) [7]. The presence of
underlying cardiovascular disease was defined as docu-
mented coronary artery disease, history of percutaneous
coronary intervention or coronary artery bypass graft sur-
gery, pathological Q waves on 12 lead ECG, diagnosis of
prior MI, history of valvular heart disease, aortic aneurysm,
or cardiomyopathy. The presence of congestive heart fail-
ure (CHF) was confirmed by physician documentation of
signs and symptoms of heart failure during the period of
hospitalization in which the I-HCA occurred [11], and by
echocardiogram showing left ventricular systolic dysfunc-
tion (EF\ 50 %) or diastolic dysfunction [12]. In order to
be included in the study, all subjects had to have at least
one documented structural heart disease as described.
2.5 Statistical analyses
Descriptive statistics were reported as means, standard
deviation, and standard errors for continuous variables.
Categorical variables were expressed in numbers and per-
centages. The Chi-squared test was used to determine the
statistical significance of differences among categorical/
continuous variables (e.g., ECG morphological changes
among cases).
Logistic regression was used to assess association
between immediate outcomes of cardiac arrest, survival to
discharge, and ECG changes (e.g. changes in heart rate and
QRS duration) and demographic variables. The change in
heart rate within 15 min prior to I-HCA for all subjects was
calculated. ANOVA and Kruskal–Wallis tests were used to
detect significant differences in heart rate and QRS dura-
tion within 8 h of cardiac arrest and their comparisons with
the last hour of cardiac arrest for all subjects. Statistical
analyses were performed using SAS software (Version 9.3;
SAS Institute Inc, Cary, NC), and Python. A p value\0.05
was considered statistically significant.




Age [mean (SD), year] 69.5 (13)
Male sex [no. (%)] 25 (64)
Location of cardiac arrest—ICU [no. (%)] 17 (44)
Initial rhythm of cardiac arrest—asystole [no. (%)] 15 (38)
Ejection fraction (n = 31), mean (SD)a 51.9 (16.2)
Body mass index (n = 36), mean (SD)a 28 (8)




Medical history [no. (%)]
Coronary artery disease 29 (76)
Congestive heart failure 15 (39)
Coronary artery bypass graft 7 (18)
Cardiomyopathy 3 (8)
Laboratory values, mean (SD)
Potassium (mEq/L) 4.4 (0.9)
Calcium (mg/dL) 8.4 (0.8)
Hemoglobin (g/dL) 10.6 (2.1)
Blood urea nitrogen (mg/dl) 40.6 (23.4)
Creatinine (mg/dl) 2.7 (2.1)
Medications [no. (%)]
Beta blockers 14 (37)
Calcium channel blockers 10 (26)






a Not all subjects had complete data and the available information of
subjects in each category was described by (n=). Data were expressed
in numbers, percentage, mean and standard deviation




During the study, 39 of 80 subjects with I-HCA from
intensive care and step-down units met inclusion criteria.
Clinical characteristics are summarized in Table 1.
Although 25 subjects (64 %) were resuscitated from
I-HCA, 17 died in hospital before discharge, and eight
survived to hospital discharge. The mean length of stay for
subjects who died in hospital was 9 ± 6 days and for
subjects who were discharged home 18 ± 8 days.
Troponin I (lg/mL) values were available in 26 subjects
(67 %), of whom 16 (62 %) had elevated levels (ranging
from 0.23 to 46.77). Brain natriuretic peptide levels were
available in 18 subjects (46 %) with a median of 801 pg/
mL (absolute median deviation = 418.5).
3.2 Survival from cardiac arrest
Amongcovariates analyzed for all subjects, only older age and
high creatinine were negatively associated with resuscitation
from I-HCA (p\ 0.05) and only older age was significantly
associated with poor survival to discharge (p\ 0.05).
Covariate analysis found no significant association between
demographic values, heart rate changes or QRS prolongation.
3.3 Changes in heart rate and QRS prolongation prior
to cardiac arrest
There were 32 subjects (82 %) who had decreased heart rate
prior to cardiac arrest. Figure 1A, B demonstrates the mean
heart rate during each of the 8 h prior to I-HCA and within
15 min of cardiac arrest in all subjects. Therewas a significant
difference in heart rate during the last hour prior to I-HCA
compared to the previous hours (p\ 0.05) as supported by
parametric (ANOVA) and non-parametric (Kruskal–Wallis)
multiple comparison tests. Pairwise hourly comparisons
showed that the hour prior to I-HCA contributed to the sig-
nificance of the tests. Mean heart rate decreased 3.0 beats per
min (bpm) within the last hour prior to I-HCA (p\ 0.01),
4.6 ± 2.5 bpm within 15–10 min (p = 0.24), 5 ± 0.5 bpm
within 10–5 min (p\ 0.01) and 7.6 ± 1.3 bpm within
5–0 min (p\ 0.01). There was no difference with respect to
the change in heart rate within the last hour or 15 min prior to
I-HCA in patients with an initial rhythms of PEA or asystole.
Different cardiac arrhythmias during the period of decreased
heart ratewere observed including sinus bradycardia,with and
without first degree atrioventricular (AV) block (47 %),
junctional rhythm (28 %), atrial fibrillation (19 %), and third
degree AV block (6 %).
Nine subjects (28 %) had a sudden decrease in heart rate
over 10–25 s during the 15 min prior to I-HCA. This
sudden decrease in heart rate was either followed by a
continuous downtrend of heart rate or an increase in heart
rate to the previous rate followed by a downtrend of heart
rate leading up to I-HCA. The maximum and minimum
heart rates were 100 and 38 bpm respectively, and the
range of difference in heart rate was 21–60 bpm with a
median of 34 in subjects with asystole and PEA. Junctional
rhythms, progression of first degree to third degree atrio-
ventricular block, and sinus bradycardia with premature
atrial contractions were observed during periods with a
sudden decrease in heart rate.
QRS prolongation was observed in 20 (51 %) subjects,
including 19 in the group with decreased heart rate prior to
I-HCA. QRS prolongation (p\ 0.01) was observed within


















































Fig. 1 Decreased heart rate prior to cardiac arrest among all subjects:
AMeanof heart ratewithin 8 h of cardiac arrest. Therewas a significance
difference between the last hour of cardiac arrest as compared with the
previous 8 h. B Red color shows the mean of heart rate within 15 min;
blue color-within 15–10 min, 10–5 min (*p\ 0.01), and 5–0 min,
(**p\ 0.01). Time ‘‘0’’ is the time of cardiac arrest
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among all subjects. QRS prolongation was significant for
both the longest mean QRS and the single longest QRS
measured in full disclosure ECG leads. There was no sig-
nificant difference between the longest mean QRS and the
single longest QRS in any ECG lead.
3.4 QRS morphology and ST segment changes prior
to cardiac arrest
The distribution of QRS morphology and ST segment
changes in all subjects is shown in Table 2. The Fig. 2
demonstrates changes with respect to the ECG leads among
all subjects with PEA and asystole. Furthermore, subjects
were separated including those with an initial rhythm of
PEA, and those with initial rhythm of asystole. The results
of ECG Changes in subjects with initial rhythms of PEA
and asystole are demonstrated in Fig. 3. Table 2
demonstrates the significant differences between these
subjects with initial rhythms of PEA and asystole.
The median time to I-HCA for the earliest changes in
QRS morphology, ST depression and ST elevation was
121 min, 13.5 min and 6.5 min, respectively. ST segment
elevation (1–5 mm) and ST depression (1–4 mm) were
observed in seven subjects (18 %). The median time for the
earliest transient changes in QRS morphology, ST
depression and ST elevation was 14, 4, and 5 min prior to
I-HCA, respectively.
If there was more than one change in QRS morphology
(e.g. notched R wave progressing to fQRS) in one lead for
a subject, then we only counted the change once. Figure 3
shows the location of the first change in any ECG lead for
each subject.
4 Discussion
Among cardiovascular subjects, we found significant ECG
changes prior to PEA and asystole. Gradually decrease in
heart rate, QRS prolongation, changes in QRS morphology
and ST segment depression and elevation were the main
findings prior to I-HCA with initial rhythms of PEA and
asystole.
We found evidence that continuous ECG monitoring
systems/telemetry are currently incapable of detecting
important ECG changes prior to cardiac arrest and alerting
clinicians of these changes. For example, the ECG system
sounds an alarm when the heart rate is high or low (e.g.,
130–200 or 40–50). However, it does not alert the clinician
when the heart rate decreases gradually from 130 to 60
beats per min. ECG changes such as a gradual decrease in
heart rate within 15 min might have an immediate prog-
nostic impact on the timely treatments of some subjects
Table 2 Distribution of QRS morphology and ST segment changes

















12 (80) 9 (38) 21 (54) 0.01
ST elevation (%) 11 (73) 9 (38) 20 (51) 0.02
ST depression
(%)
10 (67) 13 (54) 23 (59) 0.44
ST elevation or
depression (%)
10 (67) 8 (33) 18 (46) 0.04
* Chi-square was performed to detect significant differences between







































A BFig. 2 QRS morphology or ST
segment changes among all
subjects: A QRS morphology or
ST segment changes in subjects
with PEA or asystole.
B Number of subjects in the
ECG lead territory first to show
changes in QRS morphology or
ST segment deviation prior to
PEA or asystolic cardiac arrest
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with PEA and asystole, which may be particularly impor-
tant given the fact that the survival after asystole is
approximately only five percent. Our study confirms pre-
vious findings that bradycardia and/or a decreased heart
rate occur in adults experiencing I-HCA [13, 14]. However,
our study focused on cardiovascular patients with PEA and
asystole rather than a general population that developed
different types of cardiac arrhythmias including ventricular
tachycardia and fibrillation.
The findings suggest that the mechanism of the decrease
in heart rate prior to I-HCA might be due to an imbalance
between the sympathetic and parasympathetic nervous
system [15–19]. It has been reported that the chronotropic
response to vagal stimulation develops gradually when
sympathetic stimulation precedes vagal stimulation [20]. In
the remaining subjects, the high heart rates that did not
subsequently decrease could have been due to sympathetic
nervous system activity that dominated parasympathetic
activity.
To the best of our knowledge, this study is the first to
report abnormalities in ventricular conduction including
both duration and morphology of the QRS prior to I-HCA
due to PEA and asystole among cardiovascular subjects.
QRS prolongation has been considered a prognostic marker
for mortality among patients with a variety of cardiovas-
cular diseases [21–23]. Moreover, QRS fragmentation
(fQRS) has been reported to be associated with increased
mortality in patients with structural heart disease [24].
The demographic findings of our study are consistent
with previous findings that age is associated with mortality
after I-HCA [25] and the rate of survival to discharge was
approximately 20 %. It is interesting to note that the
asystole group did show greater changes in QRS mor-
phology, ST segment depression and elevation than did the
PEA group. These findings suggest that the diagnostic
clues for these two conditions could be different. Larger
studies would look to corroborate these findings.
An additional issue inherent with PEA is that the time of
arrest may not be determined precisely because patients
who experience PEA have no palpable pulse but the
monitoring system may show an ECG that is compatible
with life. We have identified diagnostic ECG clues that
warrant patient evaluation by clinicians prior to PEA and
asystole as an initial rhythm of the I-HCA. This may help
shorten the response time to cardiac arrest especially with
PEA. Future studies will be required to determine whether






































































Fig. 3 QRS morphology or ST
segment changes in asytole or
PEA group: A Asystole group,
B PEA group, C Number of
subjects in the ECG lead
territory, first to show changes
prior to asystolic cardiac arrest,
D Number of subjects in the
ECG lead territory first to show
changes prior to PEA
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An important clinical implication of this pilot study is
increased awareness of the need to use full disclosure
ECGs while monitoring two ECG leads continuously.
Analysis of the full disclosure ECG is not a standard fea-
ture for all ECG monitoring systems. Typically only one or
two ECG leads (e.g. leads II and V1) are displayed con-
tinuously. Because the full disclosure ECG is not displayed
automatically, it is not clear whether clinicians are aware
they can use this feature if it is part of their telemetry
system. The presence of QRS morphology and ST segment
changes prior to I-HCA in leads other than II and V1 in our
study supports the importance of using available full dis-
closure ECGs. Identification of ECG morphology changes
by analyzing full disclosure ECGs may preempt or
decrease response time to I-HCA due to PEA and asystole.
In conclusion, this study has identified ECG changes
using full-disclosure ECGs from continuous monitoring
systems that precede I-HCA due to PEA and asystole. The
identification of these indicators may be a first step in better
understanding the mechanism of I-HCA due to PEA and
asystole. More importantly, if these changes are more
widely known by medical professionals, they may be used,
in concert with better telemetry and continuous monitoring
systems, to prevent adverse outcomes among hospital
patients from I-HCA, including death.
Telemetry is one of the most common monitoring sys-
tems being utilized at hospitals and ECG changes from
telemetry can be potentially incorporated in the Early
Warning Scores (EWS). Different formats of EWS (e.g.,
MEWS, NEWS) predict the deteriorating condition of
patients by analyzing continuously recorded data including
a patient’s vital signs and neurological status. ECG changes
from telemetry prior to asystole and PEA can also be used
to assess patients at the risk for adverse events. Establish-
ing the ECG predictors prior to these lethal arrhythmias
through multi-center studies and creating a standard of care
for using monitoring systems including access to digital
data at hospitals may improve our ability to predict onset of
I-HCA in high risk patients, over existing clinical risk
prediction methods (e.g., EWS).
5 Limitations of study
Only cardiovascular disease subjects were included in this
study resulting in a small sample size. However, this more
homogenous population may have served as a better indi-
cator for the potential underlying mechanisms, as opposed
to a mixed population with different underlying diseases
such as trauma and cancer. Nevertheless, I-HCA is a
complex public health problem, and a larger, multi-center
study should be conducted to verify these results and shed
more light on the mechanisms of I-HCA. The present
findings should be viewed with caution before making
population-based conclusions because of small sample size
studied. Our study indicate the potential role for telemetry
in identifying patients at the risk of I-HCA and ECG
changes might add meaningful clinical data to existing
predictors (e.g., vital signs).
ECG data of hospitalized patients from telemetry is not
typically saved as part of the patient’s electronic health
records in the majority of US hospitals [26]. Therefore, only
two min of each one hour periodwithin eight hours of I-HCA
were printed. More patterns can emerge as data recording
practices become more consistent and ubiquitous.
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